Axel Gaston Glasmacher
Chairman bei 4D PHARMA PLC
Profil
Dr. Axel Gaston Glasmacher, MD, is an Independent Director at Active Biotech AB, a Non-Executive Chairman at 4D Pharma Plc, a General Director at AG Life Science Consulting Gmbh & Co. Kg, a General Director at Glasmacher Verwaltungs GmbH and a Treasurer & Director at The Cancer Drug Development Forum.
He is on the Board of Directors at AvenCell Therapeutics, Inc., Active Biotech AB, Ryvu Therapeutics SA and The Cancer Drug Development Forum.
Dr. Glasmacher was previously employed as a Senior VP-Global Clinical Research & Development by Celgene Corp.
He received his undergraduate degree from the University of Bonn and a doctorate degree from the University of Bonn.
Aktive Positionen von Axel Gaston Glasmacher
| Unternehmen | Position | Beginn |
|---|---|---|
| 4D PHARMA PLC | Chairman | 17.04.2020 |
| RYVU THERAPEUTICS S.A. | Director/Board Member | 01.10.2019 |
| ACTIVE BIOTECH AB | Director/Board Member | 01.01.2020 |
| The Cancer Drug Development Forum | Director/Board Member | - |
| AG Life Science Consulting Gmbh & Co. Kg | Chief Executive Officer | - |
| Glasmacher Verwaltungs GmbH | Chief Executive Officer | - |
AvenCell Therapeutics, Inc.
 AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Director/Board Member | 01.07.2021 |
Ehemalige bekannte Positionen von Axel Gaston Glasmacher
| Unternehmen | Position | Ende |
|---|---|---|
| CELGENE | Chief Tech/Sci/R&D Officer | 01.02.2018 |
Ausbildung von Axel Gaston Glasmacher
| University of Bonn | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ACTIVE BIOTECH AB | Health Technology |
| RYVU THERAPEUTICS S.A. | Health Technology |
| 4D PHARMA PLC | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
| The Cancer Drug Development Forum | |
| AG Life Science Consulting Gmbh & Co. Kg | |
| Glasmacher Verwaltungs GmbH | |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Health Technology |
